Cécile Kremer

Cécile Kremer

Auto-generated profile, based on publicly available information

Cécile Kremer

Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2020 in Eurosurveillance
Verified
Journal Article
Open access
CKCécile Kremer
Cécile Kremer
TGTapiwa Ganyani
Tapiwa Ganyani
DCDongxuan Chen
Dongxuan Chen
ATAndrea Torneri
Andrea Torneri
CFChristel Faes
Christel Faes
NHNiel Hens
Niel Hens
Eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.

8 July 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CKCécile Kremer
Cécile Kremer
ATAndrea Torneri
Andrea Torneri
SBSien Boesmans
Sien Boesmans
HMHanne Meuwissen
Hanne Meuwissen
SVSelina Verdonschot
Selina Verdonschot
NHNiel Hens
Niel Hens
The number of secondary cases, i.e. the number of new infections generated by an infectious individual, is an important parameter for the control of infectious diseases. When individual variation in disease transmission is present, like for COVID-19, the distribution of the number of secondary cases is skewed and often modeled using a negative binomial distribution. However, this may not always be the best distribution to describe the underlying transmission process. We propose the use of three other offspring distributions to quantify heterogeneity in transmission, and we assess the possible bias in estimates of the mean and variance of this distribution when the data generating distribution is different from the one used for inference. We also analyze COVID-19 data from Hong Kong, India, and Rwanda, and quantify the proportion of cases responsible for 80% of transmission, $$p_{80\%}$$p80% , while acknowledging the variation arising from the assumed offspring distribution. In a simulation study, we find that variance estimates may be biased when there is a substantial amount of heterogeneity, and that selection of the most accurate distribution from a set of distributions is important. In addition we find that the number of secondary cases for two of the three COVID-19 datasets is better described by a Poisson-lognormal distribution.

1 August 2022 in Emerging Infectious Diseases
Verified
Journal Article
Open access
CKCécile Kremer
Cécile Kremer
TBToon Braeye
Toon Braeye
KPKristiaan Proesmans
Kristiaan Proesmans
EAEmmanuel André
Emmanuel André
ATAndrea Torneri
Andrea Torneri
NHNiel Hens
Niel Hens
Serial Intervals for SARS-CoV-2 Variants, Belgium

27 July 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DBDana Busschots
Dana Busschots
CKCécile Kremer
Cécile Kremer
RBRob Bielen
Rob Bielen
ÖKÖzgür M. Koc
Özgür M. Koc
LHLeen Heyens
Leen Heyens
GRGeert Robaeys
Geert Robaeys
Background: Prevalence data on viral hepatitis B (HBV), hepatitis C (HCV), and HIV infection in prison are often scarce or outdated. There is currently no systematic screening for these blood-borne viral infections (BBV) in Belgian prisons. There is an urgency to assess the prevalence of these BBV to inform policymakers and public healthcare. Methods: This was a multicentre, interventional study to assess the prevalence of BBV using opt-in screening in prisons across Belgium, April 2019 – March 2020. Prisoners were tested using a finger prick and BBV risk factors were assessed using a questionnaire. A generalized linear mixed model was used to investigate the association between the various risk factors and HCV. Results: In total, 886 prisoners from 11 Belgian prisons were screened. Study uptake ranged from 16.9 to 35.4% in long-term facilities. The prevalence of HCV antibodies (Ab), hepatitis B surface antigen (Ag) and HIV Ab/Ag was 5.0% (44/886), 0.8% (7/886), and 0.2% (2/886). The adjusted odds for HCV Ab were highest in prisoners who ever injected (p < 0.001; AOR 24.6 CI 95% (5.5–215.2). The prevalence of detectable HCV RNA in the total cohort was 2.1% (19/886). Thirteen (68.4%) prisoners were redirected for follow-up of their HCV infection. Conclusions: Opt-in testing for viral hepatitis B, C and HIV was relatively well-accepted in prisons. Compared with the general population, prisoners have a higher prevalence of infection with BBV, especially for HCV. Systematic screening for these BBV should be recommended in all prisons, preferably using opt-out to optimize screening uptake. Trial registration: Retrospectively registered at clinical trials NCT04366492 April 29, 2020.

7 December 2018 in Liver International
Verified
Journal Article
Closed access
PDF file
RBRob Bielen
Rob Bielen
CKCécile Kremer
Cécile Kremer
ÖKÖzgür M. Koc
Özgür M. Koc
DBDana Busschots
Dana Busschots
DHDiana Hendrickx
Diana Hendrickx
GRGeert Robaeys
Geert Robaeys

22 March 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
CKCécile Kremer
Cécile Kremer
AKAnatoli Kamali
Anatoli Kamali
MKMonica Kuteesa
Monica Kuteesa
JSJanet Seeley
Janet Seeley
NHNiel Hens
Niel Hens
RNRebecca N Nsubuga
Rebecca N Nsubuga
Background: In countries with mature generalized HIV epidemics such as Uganda, there are still groups of individuals that are disproportionately affected. Among the key populations in Uganda are fishing communities, which make up about 10% of the population. Compared to the general population, HIV prevalence and incidence among individuals living in these communities is high. This high HIV burden has been attributed to several factors including limited access to prevention and treatment services as well as ongoing high-risk sexual behaviour. Methods: We investigated the impact of combined HIV prevention interventions on HIV transmission dynamics in high-risk fishing communities in Uganda using a deterministic compartmental model. The model was calibrated to seroprevalence data from a census performed in 2014. To account for remaining uncertainty in the calibrated model parameters, 50 000 simulated scenarios were modelled to investigate the impact of combined prevention interventions. Results: The projected HIV incidence decreased from 1.87 per 100 PY without intervention scale-up to 0.25 per 100 PY after 15 years (2014–2029) of intervention scale-up. A potential combination achieving this 87% reduction in incidence over 15 years in Ugandan FCs included condom use in about 60% of sexual acts, 23% of susceptible men circumcised, 87% of people living with HIV aware of their status, 75% of those on ART, and about 3% of susceptible individuals on oral PrEP. Uncertainty analysis revealed relative reductions in incidence ranging from 30.9 to 86.8%. Sensitivity analyses suggested that condom use and early ART were the most important interventions. Conclusion: Reducing HIV incidence, as well as prevalence and AIDS-related mortality, in these high-risk fishing communities in Uganda is attainable over 15 years with a combination prevention package. Our projected intervention coverage levels are well within the national targets set by the Uganda government and enable coming close to reaching the UNAIDS 95-95-95 targets to end AIDS as a public health threat by 2030.